Agios to Webcast Conference Call of Third Quarter 2024 Financial Results on October 31, 2024

GlobeNewswireOct 17 07:00 ET

Agios Pharmaceuticals Price Target Announced at $51.00/Share by Scotiabank

Dow JonesOct 16 10:35 ET · Ratings

Leerink Partners Maintains Agios Pharmaceuticals(AGIO.US) With Hold Rating

Moomoo NewsOct 15 03:32 ET · Ratings

4 Analysts Have This To Say About Agios Pharmaceuticals

BenzingaOct 10 10:01 ET

Raymond James Upgrades Agios Pharmaceuticals(AGIO.US) to Buy Rating, Announces Target Price $51

Moomoo NewsOct 10 09:31 ET · Ratings

Express News | Raymond James Reinstates Outperform on Agios Pharmaceuticals, Announces $51 Price Target

BenzingaOct 10 08:54 ET